Prudential Jennison Health Sciences Class R (PJHRX)

Net Asset Value
1 Day
Overall Morningstar Rating
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.


1 month+3.38% 3 years+36.70%
3 months+12.80% 5 years--
1 year+44.89% Since inception+36.11%
Data through --

Peer Comparisonvs. Health

Performance 5-yr return--+21.57%
Expense ratio1.60%1.45%
Risk 5 year sharpe ratio1.571.52
Net assets$3.4B$3.7B
Average market cap$11.7B$32.9B
Average P/E--26.3
Portfolio turnover57%57%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 15 Years
Minimal initial investment$0.00
Minimum IRA investment--


U.S. stock75.42%
International stock15.05%
Fixed income1.72%
Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical Inc5.36%
INCY Incyte Corp4.03%
SHPG Shire4.01%
CELG Celgene3.46%
BIIB Biogen3.37%
MDT Medtronic PLC3.29%
PCRX Pacira Pharmaceuticals Inc2.76%
AZN AstraZeneca2.57%
ILMN Illumina Inc2.54%
ICPT Intercept Pharmaceuticals Inc2.43%

To view my watchlist

Not a member yet?

Sign up now for a free account